Fig. 1.
Forest plot with pooled effects and 95% confidence interval (CI) indicating the association between interleukin-6 (IL-6) level and adverse outcomes in coronavirus disease 2019 patients (a). Subgroup analysis based on different disease outcomes (severe (b), ICU (intensive care unit) admission (c), death (d)). Sensitivity analysis (e).